Rezai, K., Urien, S., Isambert, N., Roche, H., Dieras, V., Berille, J., . . . Lokiec, F. (2011). Pharmacokinetic evaluation of the vinorelbine–lapatinib combination in the treatment of breast cancer patients. Cancer chemotherapy and pharmacology, 68(6), 1529-1536. https://doi.org/10.1007/s00280-011-1650-8
Chicago Style (17th ed.) CitationRezai, Keyvan, S. Urien, N. Isambert, H. Roche, V. Dieras, J. Berille, J. Bonneterre, E. Brain, and F. Lokiec. "Pharmacokinetic Evaluation of the Vinorelbine–lapatinib Combination in the Treatment of Breast Cancer Patients." Cancer Chemotherapy and Pharmacology 68, no. 6 (2011): 1529-1536. https://doi.org/10.1007/s00280-011-1650-8.
MLA (9th ed.) CitationRezai, Keyvan, et al. "Pharmacokinetic Evaluation of the Vinorelbine–lapatinib Combination in the Treatment of Breast Cancer Patients." Cancer Chemotherapy and Pharmacology, vol. 68, no. 6, 2011, pp. 1529-1536, https://doi.org/10.1007/s00280-011-1650-8.